MARKET

RGNT

RGNT

Regentis Biomaterials Ltd
AMEX
1.490
-0.060
-3.87%
Pre Market: 1.490 0 0.00% 04:01 10/19 EDT
OPEN
1.600
PREV CLOSE
1.550
HIGH
1.600
LOW
1.460
VOLUME
22
TURNOVER
--
52 WEEK HIGH
15.50
52 WEEK LOW
1.232
MARKET CAP
10.47M
P/E (TTM)
-3.4120
1D
5D
1M
3M
1Y
5Y
1D
Regentis Biomaterials (NYSE American: RGNT) Reports Strong Surgeon Interest in GelrinC at International Cartilage Summit
TipRanks · 5d ago
Regentis Biomaterials (NYSE American: RGNT) to Present at 2026 ThinkEquity Conference on Oct. 15
TipRanks · 6d ago
Regentis Biomaterials reports ‘strong’ surgeon interest in GelrinC
TipRanks · 6d ago
Weekly Report: what happened at RGNT last week (1005-1009)?
Weekly Report · 6d ago
Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
Barchart · 10/09 15:05
Weekly Report: what happened at RGNT last week (0928-1002)?
Weekly Report · 10/05 10:34
Regentis Biomaterials Is Addressing the ‘Short-Term Relief, Long-Term Failure’ Problem in Knee Cartilage Repair
TipRanks · 10/02 16:00
Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care
TipRanks · 09/29 16:30
More
About RGNT
Regentis Biomaterials Ltd is an Israel-based regenerative medicine company. The Company is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Its lead product is GellinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage. Its implant combines the precision of photopolymerization with the biocompatibility of PEG and fibrinogen, enabling natural tissue regeneration without the need for cell harvesting or culturing. Regentis Biomaterials Ltd aims to address unmet clinical needs in sports medicine and early-stage osteoarthritis.

Webull offers Regentis Biomaterials Ltd stock information, including AMEX: RGNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGNT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGNT stock methods without spending real money on the virtual paper trading platform.